Exagen (XGN) Stock Price, Quote, News & History | Benzinga

Exagen Inc (XGN) Stock Price, Quote, News & History

XGNNASDAQ

Trade with Public

Trade with Public

$7.92

0.141.8%

At close: Aug 21, 5:00 PM EST

$7.92

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$7.83

Close

$7.92

Volume / Avg.

251.71K / 355.41K

Day Range

$7.62 - $7.99

52 Wk Range

2.59 - 12.23

Market Cap

$191.35M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

78

Short Interest

4.13%

Days to Cover

4.17

Recent Exagen Inc. News

Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio.

Zacks

Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday

With US futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Lisa Levin

Partner Content

Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments

Houston, Texas-based Coya Therapeutics Inc. (NASDAQ: COYA) has just taken a giant leap in making effective proprietary treatments focused on certain neurodegenerative and autoimmune diseases available to more patients, as it announced the expansion of its exclusive worldwide rights for the development and c

FTC Solar, Exagen And 2 Other Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones closed lower by over 300 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-6.50M

Investing Cash Flow (TTM)

-1.08M

Financing Cash Flow (TTM)

2.13M

Free Cash Flow (TTM)

-7.59M

Capital Expenditure (TTM)

-1.09M

Net Change in Cash (TTM)

-5.45M

Analyst Trends and Forecast

1

Apr

1

May

1

Jun

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$189.92M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.59

PB Ratio (TTM)

15.43

Earnings Yield % (TTM)

-10.54%

Earnings Yield % (FWD)

-8.68%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.50

Company Debt

Total Debt

$22.84M

LT Debt

$22.32M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-$1.41M

Total Cash

$24.59M

Debt to Equity

2.13

Issuance of Debt (TTM)

-$1.41M

Repayment of Debt (TTM)

-$1.41M

Key Statistics

Open

$7.83

Close

$7.92

Volume / Avg.

251.71K / 355.41K

Day Range

$7.62 - $7.99

52 Wk Range

2.59 - 12.23

Market Cap

$191.35M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

78

Short Interest

4.13%

Days to Cover

4.17

About

Sector

Health Care

Industry

Biotechnology

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Exagen (XGN) stock?

A

You can purchase shares of Exagen (NASDAQ:XGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Exagen (XGN) competitors?

A

Other companies in Exagen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Exagen (XGN) stock?

A

Exagen has a consensus price target of $9.25.

Q

What is the current price for Exagen (XGN)?

A

The stock price for Exagen (NASDAQ: XGN) is $7.92 last updated August 21, 2026 at 4:00 PM EDT.

Q

Does Exagen (XGN) pay a dividend?

A

There are no upcoming dividends for Exagen.

Q

When is Exagen (NASDAQ:XGN) reporting earnings?

A

Exagen does not have any upcoming earnings scheduled.

Q

Is Exagen (XGN) going to split?

A

There is no upcoming split for Exagen.

Q

What sector and industry does Exagen (XGN) operate in?

A

Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.